Monopar Therapeutics (MNPR) Share-based Compensation (2017 - 2025)
Quarterly results put Share-based Compensation at -$3.7 million for Q4 2025, down 1440.13% from a year ago — trailing twelve months through Dec 2025 was -$1.2 million (down 253.47% YoY), and the annual figure for FY2024 was $1.1 million, down 39.89%.
Monopar Therapeutics has reported Share-based Compensation over the past 9 years, most recently at -$3.7 million for Q4 2025.
- Share-based Compensation reached -$3.7 million in Q4 2025 per MNPR's latest filing, down from $617413.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $1.4 million in Q1 2025 and bottomed at -$3.7 million in Q4 2025.
- Median Share-based Compensation over the past 5 years was $357593.0 (2021), compared with a mean of $178382.8.
- Peak annual rise in Share-based Compensation hit 4469.37% in 2025, while the deepest fall reached 1440.13% in 2025.
- Over 5 years, Share-based Compensation stood at $392065.0 in 2021, then grew by 0.34% to $393417.0 in 2022, then grew by 20.54% to $474206.0 in 2023, then plummeted by 41.25% to $278612.0 in 2024, then tumbled by 1440.13% to -$3.7 million in 2025.
- Business Quant data shows Share-based Compensation for MNPR at -$3.7 million in Q4 2025, $617413.0 in Q3 2025, and $567957.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 257.40 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - | -3.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.73 Mn |
| Dec 31, 2025 | -3.73 Mn |
| Sep 30, 2025 | 617,413.00 |
| Sep 30, 2025 | 617,413.00 |
| Jun 30, 2025 | 567,957.00 |
| Jun 30, 2025 | 567,957.00 |
| Mar 31, 2025 | 1.36 Mn |
| Mar 31, 2025 | 1.36 Mn |
| Dec 31, 2024 | 278,612.00 |
| Dec 31, 2024 | 278,612.00 |
| Sep 30, 2024 | 13,512.00 |
| Sep 30, 2024 | 13,512.00 |
| Jun 30, 2024 | 156,822.00 |
| Jun 30, 2024 | 156,822.00 |
| Mar 31, 2024 | 328,661.00 |
| Mar 31, 2024 | 328,661.00 |
| Dec 31, 2023 | 474,206.00 |
| Dec 31, 2023 | 474,206.00 |
| Sep 30, 2023 | 217,468.00 |
| Sep 30, 2023 | 217,468.00 |
| Jun 30, 2023 | 216,999.00 |
| Jun 30, 2023 | 216,999.00 |
| Mar 31, 2023 | 476,209.00 |
| Mar 31, 2023 | 476,209.00 |
| Dec 31, 2022 | 393,417.00 |
| Dec 31, 2022 | 393,417.00 |
| Sep 30, 2022 | 204,360.00 |
| Sep 30, 2022 | 204,360.00 |
| Jun 30, 2022 | 204,692.00 |
| Jun 30, 2022 | 204,692.00 |
| Mar 31, 2022 | 499,812.00 |
| Mar 31, 2022 | 499,812.00 |
| Sep 30, 2021 | 392,065.00 |
| Sep 30, 2021 | 392,065.00 |
| Jun 30, 2021 | 357,593.00 |
| Jun 30, 2021 | 357,593.00 |
| Mar 31, 2021 | 368,232.00 |
| Mar 31, 2021 | 368,232.00 |
| Dec 31, 2020 | 331,322.00 |
| Dec 31, 2020 | 331,322.00 |
| Sep 30, 2020 | 283,713.00 |
| Sep 30, 2020 | 283,713.00 |
| Jun 30, 2020 | 367,358.00 |
| Jun 30, 2020 | 367,358.00 |
| Mar 31, 2020 | 338,497.00 |
| Mar 31, 2020 | 338,497.00 |
| Dec 31, 2019 | 276,805.00 |
| Dec 31, 2019 | 276,805.00 |
| Sep 30, 2019 | 242,956.00 |
| Sep 30, 2019 | 242,956.00 |
| Jun 30, 2019 | 257,633.00 |
| Jun 30, 2019 | 257,633.00 |
| Mar 31, 2019 | 233,776.00 |
| Mar 31, 2019 | 233,776.00 |
| Dec 31, 2018 | 232,992.00 |
| Dec 31, 2018 | 232,992.00 |
| Sep 30, 2018 | 93,244.00 |
| Sep 30, 2018 | 93,244.00 |
| Jun 30, 2018 | 88,570.00 |
| Jun 30, 2018 | 88,570.00 |
| Mar 31, 2018 | 114,526.00 |
| Mar 31, 2018 | 114,526.00 |
| Dec 31, 2017 | 63,189.00 |
| Dec 31, 2017 | 63,189.00 |
| Sep 30, 2017 | 3,612.00 |
| Sep 30, 2017 | 3,612.00 |